Related Experiment Video
Updated: Jul 15, 2026

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
Structural and metabolic brain changes in the striatum associated with methamphetamine abuse
Linda Chang1, Daniel Alicata, Thomas Ernst
1Department of Medicine, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI 96813, USA. LChang@hawaii.edu
Neuroimaging reveals significant brain changes in methamphetamine users and exposed children, particularly in the basal ganglia. Further research with larger samples and longitudinal studies is needed to confirm findings and explore treatment outcomes.
Area of Science:
- Neuroimaging
- Neuroscience
- Addiction Medicine
Background:
- Methamphetamine use is associated with significant neurotoxicity.
- Prenatal exposure to methamphetamine can lead to developmental brain abnormalities.
Purpose of the Study:
- To review brain structural, chemical, and metabolic changes in methamphetamine users.
- To examine these changes in children with prenatal methamphetamine exposure, focusing on the basal ganglia.
Main Methods:
- Review of magnetic resonance imaging (MRI) and positron emission tomography (PET) studies.
- Inclusion of relevant pre-clinical studies for interpretation.
Main Results:
- Adult users show enlarged striatal volumes but reduced neuronal markers in the basal ganglia.
- Exposed children exhibit smaller striatal structures and elevated total creatine.
- Reduced dopamine transporter (DAT) density, dopamine D(2) receptors, and altered glucose metabolism were observed in users.
Conclusions:
- Neuroimaging confirms brain structure and chemistry abnormalities in methamphetamine users and exposed children, especially in the striatum.
- Larger sample sizes and longitudinal studies are required for validation and to assess treatment effects.
- Potential for imaging and genetic markers to predict treatment outcomes warrants further investigation.
Related Concept Videos
Alzheimer Disease ll: Pathophysiology
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Drug Abuse and Addiction: Pharmacological Phenomena
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.

